NCT05852990 2026-04-09
Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC
Instituto Nacional de Cancerologia de Mexico
Phase 3 Recruiting
Clinical Trials
12 trialsNCT07287592 2025-12-17
Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.
Ain Shams University
Phase 3 Not yet recruiting
NCT01952847 2022-06-15
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT01179217 2020-08-19
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
Phase 3 Completed
NCT00195013 2018-06-06
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Weill Medical College of Cornell University
Phase 3 Completed
NCT01032512 2018-02-19
Clinical Benefits of Preoperative Nutrition Support With Enteral Immune-enhancing Formulas in Surgical Oncology
University of Chile
Phase 3 Withdrawn
NCT00003170 2016-07-14
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00006994 2015-11-18
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
SWOG Cancer Research Network
Phase 3 Terminated
NCT02282839 2015-11-04
Oral Glutamine and Mucositis of Head and Neck Cancer Patients Undergoing Radiation
Taichung Veterans General Hospital
Phase 3 Unknown
NCT02024191 2013-12-31
GELUPO
Ankara Education and Research Hospital
Phase 3 Unknown
NCT01087658 2013-06-21
GLUTOX
Sanofi
Phase 3 Completed
NCT00455247 2013-06-05
Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects
Société des Produits Nestlé (SPN)
Phase 3 Completed